CORD-19:c738a511a9c18e7e831b40f1ec3605fe4cdeb6d1 / 9687-9850
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T57","span":{"begin":0,"end":163},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Of note, NSABP-B39 also included 800 patients with ER-breast cancer who exhibited excellent local control, suggesting that APBI may be reasonable among this group."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T57","span":{"begin":0,"end":163},"obj":"Sentence"}],"text":"Of note, NSABP-B39 also included 800 patients with ER-breast cancer who exhibited excellent local control, suggesting that APBI may be reasonable among this group."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T22","span":{"begin":54,"end":67},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"Of note, NSABP-B39 also included 800 patients with ER-breast cancer who exhibited excellent local control, suggesting that APBI may be reasonable among this group."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T30","span":{"begin":54,"end":60},"obj":"Body_part"}],"attributes":[{"id":"A30","pred":"uberon_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Of note, NSABP-B39 also included 800 patients with ER-breast cancer who exhibited excellent local control, suggesting that APBI may be reasonable among this group."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T55","span":{"begin":51,"end":67},"obj":"Disease"},{"id":"T56","span":{"begin":54,"end":67},"obj":"Disease"},{"id":"T57","span":{"begin":61,"end":67},"obj":"Disease"},{"id":"T62743","span":{"begin":51,"end":67},"obj":"Disease"},{"id":"T3603","span":{"begin":54,"end":67},"obj":"Disease"},{"id":"T79729","span":{"begin":61,"end":67},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0006513"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A25252","pred":"mondo_id","subj":"T62743","obj":"http://purl.obolibrary.org/obo/MONDO_0006513"},{"id":"A27687","pred":"mondo_id","subj":"T3603","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A29554","pred":"mondo_id","subj":"T79729","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Of note, NSABP-B39 also included 800 patients with ER-breast cancer who exhibited excellent local control, suggesting that APBI may be reasonable among this group."}